Peter Shaw

Prof. Peter Shaw

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 1992 in Nature
Verified
Journal Article
Closed access
PDF file
HGHendrik Gille
Hendrik Gille
ASAndrew D. Sharrocks
Andrew D. Sharrocks
PSPeter Shaw
Peter Shaw

1 February 1989 in Cell
Verified
Journal Article
Closed access
PSPeter Shaw
Peter Shaw
HSHennrik Schröter
Hennrik Schröter
ANAlfred Nordheim
Alfred Nordheim

1 November 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JFJeffrey A. Frost
Jeffrey A. Frost
HSHelge Steen
Helge Steen
PSPaul Shapiro
Paul Shapiro
TLTim Lewis
Tim Lewis
NANatalie Ahn
Natalie Ahn
MCMelanie H Cobb
Melanie H Cobb
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 July 1989 in Nature
Verified
Journal Article
Closed access
RHRafael E. Herrera
Rafael E. Herrera
PSPeter Shaw
Peter Shaw
ANAlfred Nordheim
Alfred Nordheim

1 May 2002 in Molecular and Cellular Biology
Verified
Journal Article
Open access
ADAmardeep S. Dhillon
Amardeep S. Dhillon
CPClaire Pollock
Claire Pollock
HSHelge Steen
Helge Steen
PSPeter Shaw
Peter Shaw
HMHarald Mischak
Harald Mischak
Walter KolchWalter Kolch
Walter Kolch
The Raf-1 kinase activates the ERK (extracellular-signal-regulated kinase) pathway. The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation. We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. Serine 43 phosphorylation decreased the binding to Ras in serum-starved but not in mitogen-stimulated cells. However, the kinase activity of a RafS43A mutant was fully inhibited by PKA. Mutation of serine 259 increased the basal Raf-1 activity and rendered it largely resistant to inhibition by PKA. cAMP increased Raf-1 serine 259 phosphorylation in a PKA-dependent manner with kinetics that correlated with ERK deactivation. PKA also decreased Raf-1 serine 338 phosphorylation of Raf-1, previously shown to be required for Raf-1 activation. Serine 338 phosphorylation of a RafS259A mutant was unaffected by PKA. Using RafS259 mutants we also demonstrate that Raf-1 is the sole target for PKA inhibition of ERK and ERK-induced gene expression, and that Raf-1 inhibition is mediated mainly through serine 259 phosphorylation.

1 October 1995 in Current Biology
Verified
Journal Article
Closed access
HGHendrik Gille
Hendrik Gille
TSThomas Strahl
Thomas Strahl
PSPeter Shaw
Peter Shaw